Biblio
“The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-β Neurotoxicity in CB2R-/- Mice.”, J Alzheimers Dis, vol. 64, no. 3, pp. 957-971, 2018.
, “Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.”, J Alzheimers Dis, vol. 54, no. 1, pp. 359-71, 2016.
, “Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.”, J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
, “The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1255-1267, 2017.
, “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 901-912, 2024.
, “Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 51, no. 1, pp. 45-55, 2016.
, “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
, “Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 699-707, 2016.
, “Role of Glutamate and NMDA Receptors in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1041-1048, 2017.
, “Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1683-1692, 2017.
, “Quantitative Proteomics Reveals the Mechanism of Oxygen Treatment on Lenses of Alzheimer's Disease Model Mice.”, J Alzheimers Dis, vol. 54, no. 1, pp. 275-86, 2016.
, “Cysteine-Rich Repeat Domains 2 and 4 are Amyloid-β Binding Domains of Neurotrophin Receptor p75NTR and Potential Targets to Block Amyloid-β Neurotoxicity.”, J Alzheimers Dis, vol. 63, no. 1, pp. 139-147, 2018.
, “Tau Acetylation in Entorhinal Cortex Induces its Chronic Hippocampal Propagation and Cognitive Deficits in Mice.”, J Alzheimers Dis, vol. 77, no. 1, pp. 241-255, 2020.
, “Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1417-1441, 2018.
, “Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1589-1599, 2021.
, “The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1041-1052, 2018.
, “The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.”, J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
, “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
, “Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1537-1548, 2017.
, “Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 83, no. 1, pp. 423-433, 2021.
, “Waist Circumference and Domain-Specific Cognitive Function Among Non-Demented Japanese Older Adults Stratified by Sex: Results from the Takashima Cognition Study.”, J Alzheimers Dis, vol. 73, no. 3, pp. 887-896, 2020.
, “Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 63, no. 2, pp. 861-869, 2018.
, “Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.”, J Alzheimers Dis, 2015.
, “A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
, “Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1417-1427, 2017.
,